Apella Capital, LLC
Source: SEC Form 13F · as of Mar 2026Apella Capital, LLC holds 27 biotech & pharma companies tracked by BioSniper, totaling $46.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
27
Total value held
$46.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 43,153 | $10.1M |
| PMPhilip Morris International Inc | 42,037 | $6.6M |
| WSTWest Pharmaceutical Services Inc. | 16,838 | $4.6M |
| MRKMerck & Co., Inc. | 37,137 | $4.4M |
| ABBVAbbVie Inc. | 20,298 | $4.2M |
| LLYELI LILLY & Co | 4,137 | $3.8M |
| XERSXeris Biopharma Holdings, Inc. | 235,897 | $1.5M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,312 | $1.4M |
| PFEPFIZER INC | 49,643 | $1.4M |
| ABTABBOTT LABORATORIES | 11,799 | $1.1M |
| AMGNAMGEN INC | 3,025 | $1.1M |
| ELVElevance Health Inc. | 2,857 | $923K |
| BMYBRISTOL MYERS SQUIBB CO | 12,802 | $770K |
| CLDXCelldex Therapeutics, Inc. | 17,024 | $588K |
| AVXLANAVEX LIFE SCIENCES CORP. | 153,006 | $557K |
| MCKMcKesson Corporation | 592 | $513K |
| NVSNovartis AG | 2,908 | $442K |
| CORCencora Inc. | 970 | $318K |
| GILDGILEAD SCIENCES, INC. | 2,281 | $314K |
| AZNASTRAZENECA PLC | 1,452 | $297K |
| NERVMinerva Neurosciences, Inc. | 42,250 | $284K |
| GMOptec International, Inc. | 2,677 | $218K |
| IQVIQVIA Holdings Inc. | 1,196 | $211K |
| UTHRUNITED THERAPEUTICS Corp | 344 | $202K |
| OMEROMEROS CORP | 14,288 | $192K |
| PGENPRECIGEN, INC. | 28,985 | $115K |
| OPKOPKO HEALTH, INC. | 27,021 | $34K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.